Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Research and Application of Mesenchymal Stem Cells and Related Technologies	941.00K	636.00K	2.12M	51.47M
Research and Application of Mesenchymal Stem Cells and Related Technologies Growth	47.96%	-70.01%	-95.88%	-
Total	941.00K	636.00K	2.12M	51.47M
Total Growth	47.96%	-70.01%	-95.88%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Taiwan	941.00K	636.00K	1.91M	-
Taiwan Growth	47.96%	-66.67%	-	-
Japan	-	-	213.00K	35.21M
Japan Growth	-	-	-99.40%	-
South Korea	-	-	-	16.26M
Total	941.00K	636.00K	2.12M	51.47M
Total Growth	47.96%	-70.01%	-95.88%	-

Source: S&P Global Market Intelligence.